


Akroswiss Revenue
Pharmaceutical Manufacturing • Zug, Zug, Switzerland • 1-10 Employees
Akroswiss revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $1,400,000 |
| Total funding | $3,300,000 |
Key Contact at Akroswiss
Jonas Steinhauser
Research & Development Director
Company overview
| Headquarters | Baarstrasse 2, Zug, 6300, CH |
| Phone number | +41417276787 |
| Website | |
| NAICS | 3254 |
| Employees | 1-10 |
| Socials |
Akroswiss Email Formats
Akroswiss uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@akroswiss.ch), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@akroswiss.ch | 100% |
About Akroswiss
Akroswiss is a swiss based pharmaceutical company, fully dedicated to the development and commercialization of innovative nasal applications of midazolam. Akroswiss has successfully developed and tested a unique bi-dose nasal drug delivery device with a first-class 360° functionality which address two unmet clinical needs; efficient treatment of epileptic seizures (rescue medication use) and conscious sedation ahead of diagnostic interventions against claustrophobia and restlessness (anxiolytic use). Akroswiss is pursuing European market authorization of its midazolam product portfolio and is currently compiling all documentation required for EMA submission.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Akroswiss Tech Stack
Discover the technologies and tools that power Akroswiss's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
PaaS
Blogs
Miscellaneous
Programming languages
Miscellaneous
Security
JavaScript frameworks
Blogs
IaaS
Frequently asked questions
4.8
40,000 users



